Dare Bioscience, Inc. (DARE): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2024-08-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

14.50M
As of 2025-12-31
15.17M
As of 2026-06-30
84.83M2013-12-31: 785.5K2014-12-31: 20.13M2015-12-31: 27.35M2016-12-31: 910.0K2017-12-31: 6.05M2018-12-31: 11.42M2019-12-31: 19.68M2020-12-31: 41.60M2021-12-31: 83.94M2022-12-31: 84.83M2023-12-31: 8.33M2024-12-31: 8.70M2025-12-31: 14.50M14.50M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3114.50M+66.7%2026-03-26, Balance as of period end
2024-12-318.70M+4.4%2026-03-26, Balance as of period end
2023-12-318.33Mn/c2025-03-31, Balance as of period end
2022-12-3184.83M+1.0%2024-03-28, Balance as of period end
2021-12-3183.94Mn/c2023-03-30, Balance as of period end
2020-12-3141.60M+111.3%2022-03-31, Balance as of period end
2019-12-3119.68M+72.3%2021-03-30, Balance as of period end
2018-12-3111.42M+88.9%2020-03-27, Balance as of period end
2017-12-316.05M+564.5%2019-04-01, Balance as of period end
2016-12-31910.0K-96.7%2018-03-28, Balance as of period end
2015-12-3127.35M+35.9%2017-06-13, Balance as of period end
2014-12-3120.13Mn/m2016-03-10, Balance as of period end
2013-12-31785.5Kn/a2015-03-19, Balance as of period end